ConditionEnd Stage Renal Disease
Trial statusNot yet recruiting
Trial phasePhase 1
Trial typeInterventional
Biological sexAll
Age18-70
SponsorXeno Holdings (US), LLC dba ChoironeX
About this trial
The goal of this clinical trial is to learn if a GalKO Porcine Thymokidney can maintain renal function, without the need for dialysis, after transplantation into adult subjects with End Stage Renal Disease.
Eligibility criteria
Qualifiers
ESRD receiving hemodialysis or peritoneal dialysis for ≥6 months
Eligible for kidney transplantation per site criteria
<50% likelihood of receiving a standard deceased-donor kidney transplant within 12 months
Blood type and immunologic compatibility with study transplant confirmed by testing
Disqualifiers
Requirement for multi-organ transplantation
Living donor available who is ABO-incompatible
Kidney disease with high risk of post-transplant recurrence
Polycystic kidney disease without prior native nephrectomy
Trial design
Treatments tested in this trial
- ChoironeX GalKO Porcine Thymokidney
Treatment groups
4 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov